Literature DB >> 21285405

High muscle lipid content in obesity is not due to enhanced activation of key triglyceride esterification enzymes or the suppression of lipolytic proteins.

Minghua Li1, Christopher Paran, Nathan E Wolins, Jeffrey F Horowitz.   

Abstract

The mechanisms underlying alterations in muscle lipid metabolism in obesity are poorly understood. The primary aim of this study was to compare the abundance and/or activities of key proteins that regulate intramyocellular triglyceride (IMTG) concentration in the skeletal muscle obtained from obese (OB; n = 8, BMI 38 ± 1 kg/m(2)) and nonobese (NOB; n = 9, BMI 23 ± 1 kg/m(2)) women. IMTG concentration was nearly twofold greater in OB vs. NOB subjects (75 ± 15 vs. 40 ± 8 μmol/g dry wt, P < 0.05). In contrast, the activity and protein abundance of key enzymes that regulate the esterification of IMTG (i.e., glycerol-3-phosphate acyltransferase and diacylglycerol acyltransferase) were not elevated. We also found no differences between groups in muscle adipose triglyceride lipase and hormone-sensitive lipase (HSL) protein abundance and no differences in phosphorylation of specific sites known to affect HSL activity. However, we did find the elevated IMTG in obesity to be accompanied by a greater abundance of the fatty acid transporter FAT/CD36 in the membrane fraction of muscle from OB vs. NOB subjects (P < 0.05), suggestive of an elevated fatty acid transport capacity. Additionally, protein abundance of the lipid-trafficking protein perilipin 3 was lower (P < 0.05) in muscle from OB vs. NOB when expressed relative to IMTG content. Our findings indicate that the elevated IMTG content found in obese women was not due to an upregulation of key lipogenic proteins or to the suppression of lipolytic proteins. The impact of a low perilipin protein abundance relative to the amount of IMTG in obesity remains to be clarified.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21285405      PMCID: PMC3074947          DOI: 10.1152/ajpendo.00316.2010

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  50 in total

Review 1.  Percutaneous needle biopsy of skeletal muscle in physiological and clinical research.

Authors:  J Bergstrom
Journal:  Scand J Clin Lab Invest       Date:  1975-11       Impact factor: 1.713

Review 2.  Markers of hydration status.

Authors:  S M Shirreffs
Journal:  Eur J Clin Nutr       Date:  2003-12       Impact factor: 4.016

3.  Posttranscriptional control of the expression and function of diacylglycerol acyltransferase-1 in mouse adipocytes.

Authors:  Yi-Hao Yu; Yiying Zhang; Peter Oelkers; Stephen L Sturley; Daniel J Rader; Henry N Ginsberg
Journal:  J Biol Chem       Date:  2002-10-28       Impact factor: 5.157

4.  Intramuscular lipid content is increased in obesity and decreased by weight loss.

Authors:  B H Goodpaster; R Theriault; S C Watkins; D E Kelley
Journal:  Metabolism       Date:  2000-04       Impact factor: 8.694

5.  Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat.

Authors:  S J Smith; S Cases; D R Jensen; H C Chen; E Sande; B Tow; D A Sanan; J Raber; R H Eckel; R V Farese
Journal:  Nat Genet       Date:  2000-05       Impact factor: 38.330

6.  Increased insulin and leptin sensitivity in mice lacking acyl CoA:diacylglycerol acyltransferase 1.

Authors:  Hubert C Chen; Steven J Smith; Zuleika Ladha; Dalan R Jensen; Luis D Ferreira; Leslie K Pulawa; James G McGuire; Robert E Pitas; Robert H Eckel; Robert V Farese
Journal:  J Clin Invest       Date:  2002-04       Impact factor: 14.808

7.  Overexpression of mitochondrial GPAT in rat hepatocytes leads to decreased fatty acid oxidation and increased glycerolipid biosynthesis.

Authors:  Daniel Lindén; Lena William-Olsson; Magdalena Rhedin; Anna-Karin Asztély; John C Clapham; Sandra Schreyer
Journal:  J Lipid Res       Date:  2004-04-21       Impact factor: 5.922

8.  Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36.

Authors:  Arend Bonen; Michelle L Parolin; Gregory R Steinberg; Jorge Calles-Escandon; Narendra N Tandon; Jan F C Glatz; Joost J F P Luiken; George J F Heigenhauser; David J Dyck
Journal:  FASEB J       Date:  2004-05-07       Impact factor: 5.191

9.  Reduced plasma FFA availability increases net triacylglycerol degradation, but not GPAT or HSL activity, in human skeletal muscle.

Authors:  Matthew J Watt; Anna G Holmes; Gregory R Steinberg; Jose L Mesa; Bruce E Kemp; Mark A Febbraio
Journal:  Am J Physiol Endocrinol Metab       Date:  2004-01-28       Impact factor: 4.310

Review 10.  Molecular mechanisms regulating hormone-sensitive lipase and lipolysis.

Authors:  C Holm
Journal:  Biochem Soc Trans       Date:  2003-12       Impact factor: 5.407

View more
  10 in total

1.  Lkb1 deletion promotes ectopic lipid accumulation in muscle progenitor cells and mature muscles.

Authors:  Tizhong Shan; Pengpeng Zhang; Pengpeng Bi; Shihuan Kuang
Journal:  J Cell Physiol       Date:  2015-05       Impact factor: 6.384

2.  Subcellular lipid droplet distribution in red and white muscles in the obese Zucker rat.

Authors:  J S V Lally; L A Snook; X X Han; A Chabowski; A Bonen; G P Holloway
Journal:  Diabetologia       Date:  2011-11-19       Impact factor: 10.122

Review 3.  Skeletal muscle lipid flux: running water carries no poison.

Authors:  Katsuhiko Funai; Clay F Semenkovich
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-05-10       Impact factor: 4.310

4.  Suppression in growth hormone during overeating ameliorates the increase in insulin resistance and cardiovascular disease risk.

Authors:  Andrea S Cornford; Ariel L Barkan; Alexander Hinko; Jeffrey F Horowitz
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-09-25       Impact factor: 4.310

5.  Extremely rapid increase in fatty acid transport and intramyocellular lipid accumulation but markedly delayed insulin resistance after high fat feeding in rats.

Authors:  Arend Bonen; Swati S Jain; Laelie A Snook; Xiao-Xia Han; Yuko Yoshida; Kathryn H Buddo; James S Lally; Elizabeth D Pask; Sabina Paglialunga; Marie-Soleil Beaudoin; Jan F C Glatz; Joost J F P Luiken; Ewa Harasim; David C Wright; Adrian Chabowski; Graham P Holloway
Journal:  Diabetologia       Date:  2015-07-22       Impact factor: 10.122

6.  Rapid development of systemic insulin resistance with overeating is not accompanied by robust changes in skeletal muscle glucose and lipid metabolism.

Authors:  Andrea S Cornford; Alexander Hinko; Rachael K Nelson; Ariel L Barkan; Jeffrey F Horowitz
Journal:  Appl Physiol Nutr Metab       Date:  2012-11-21       Impact factor: 2.665

7.  Intramuscular triglyceride synthesis: importance in muscle lipid partitioning in humans.

Authors:  Bryan C Bergman; Leigh Perreault; Allison Strauss; Samantha Bacon; Anna Kerege; Kathleen Harrison; Joseph T Brozinick; Devon M Hunerdosse; Mary C Playdon; William Holmes; Hai Hoang Bui; Phil Sanders; Parker Siddall; Tao Wei; Melissa K Thomas; Ming Shang Kuo; Robert H Eckel
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-10-03       Impact factor: 4.310

8.  Intestinal mucosal triacylglycerol accumulation secondary to decreased lipid secretion in obese and high fat fed mice.

Authors:  John D Douglass; Nashmia Malik; Su-Hyoun Chon; Kevin Wells; Yin Xiu Zhou; Andrew S Choi; Laurie B Joseph; Judith Storch
Journal:  Front Physiol       Date:  2012-02-24       Impact factor: 4.566

Review 9.  Roles of chronic low-grade inflammation in the development of ectopic fat deposition.

Authors:  Lulu Liu; Mei Mei; Shumin Yang; Qifu Li
Journal:  Mediators Inflamm       Date:  2014-07-21       Impact factor: 4.711

10.  Interferon-alpha 2 but not Interferon-gamma serum levels are associated with intramuscular fat in obese patients with nonalcoholic fatty liver disease.

Authors:  Giovanni Tarantino; Susan Costantini; Vincenzo Citro; Paolo Conforti; Francesca Capone; Angela Sorice; Domenico Capone
Journal:  J Transl Med       Date:  2019-01-03       Impact factor: 5.531

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.